goglides.dev
ResearchFinanceTechCompaniesDiscussion
Search
Sign inJoin
goglidesgoglides.devSocial learning for Finance and Tech.
TermsPrivacyDisclaimerModerationAcceptable UseDMCAContact
Company / Finance

Vertex Pharmaceuticals Incorporated

VRTX · UNKNOWN

Vertex reported FY2025 revenue of $12.00 billion and Q1 2026 revenue of $2.99 billion, with the official record tying the thesis to cystic-fibrosis durability, pipeline diversification, cash conversion and R&D execution.

FollowAdd to WatchlistAsk Question
Coverage BootstrapNASDAQVertex Pharmaceuticals IncorporatedVRTX
OverviewFinancialsResearchTimelineCompareValuationScorecardDiscussion
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue